1. Home
  2. BZFD vs LGVN Comparison

BZFD vs LGVN Comparison

Compare BZFD & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BuzzFeed Inc.

BZFD

BuzzFeed Inc.

HOLD

Current Price

$1.46

Market Cap

30.1M

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.80

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZFD
LGVN
Founded
2006
2014
Country
United States
United States
Employees
507
N/A
Industry
Movies/Entertainment
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.1M
34.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BZFD
LGVN
Price
$1.46
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
7.2M
379.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.76
EPS
N/A
N/A
Revenue
N/A
$709,000.00
Revenue This Year
$1.69
N/A
Revenue Next Year
$108.06
$10.81
P/E Ratio
$292.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.48
52 Week High
$2.68
$1.80

Technical Indicators

Market Signals
Indicator
BZFD
LGVN
Relative Strength Index (RSI) 54.60 49.34
Support Level $0.74 $0.74
Resistance Level $1.77 $0.86
Average True Range (ATR) 0.23 0.07
MACD -0.02 0.01
Stochastic Oscillator 23.44 78.25

Price Performance

Historical Comparison
BZFD
LGVN

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a digital media company across pop culture, entertainment, shopping, food, and news, its brands drive conversation and inspire what audiences watch, read, and buy now and into the future. Its iconic, globally-loved brands include BuzzFeed, HuffPost, and Tasty. The company generates revenue from advertising, content, commerce, and other sources.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: